Mechanisms involved in the blunted nitric oxide-cGMP pathway in hypertensive TGR(mREN2)27 rats

By Jacke K.   Witte K.   Lemmer B.  

European Journal of Pharmacology, Vol. 415, Iss. 1, 2001-03 ,pp. : 27-30

Elsevier

Access to resources Recommend Favorite

amlodipine treatment in transgenic TGR(mREN2)27 rats - a 3-year longitudinal study

By Witte K.   Schnecko A.   Schmidt T.   Voll C.   Kranzlin B.   Lemmer B.  

General Pharmacology, Vol. 33, Iss. 5, 1999-11 ,pp. : 423-430

Elsevier

Access to resources Recommend Favorite

Cardiovascular and renal effects of cyclooxygenase inhibition in transgenic rats harboring mouse renin-2 gene (TGR[mREN2]27)

By Cheng Z.J.   Finckenberg P.   Louhelainen M.   Merasto S.   Tikkanen I.   Vapaatalo H.   Mervaala E.M.A.  

European Journal of Pharmacology, Vol. 461, Iss. 2, 2003-02 ,pp. : 159-169

Elsevier

Access to resources Recommend Favorite

CHANGES OF BLOOD PRESSURE AND AORTIC STRIP CONTRACTILE RESPONSES TO ET-1 OF HETEROZYGOUS FEMALE TRANSGENIC RATS, TGR(mREN2)27

By Cargnelli G.   Rossi G.P.A.O.L.O.   Pessina A.C.   Luciani S.   debetto P.   Ganten D.   Peters J.   Bova S.  

Pharmacological Research, Vol. 37, Iss. 3, 1998-03 ,pp. : 207-211

Academic Press

Access to resources Recommend Favorite

Hippocampal 5-HT and NE release in the transgenic rat TGR(mREN2)27 related to behavior on the elevated plus maze

By Voigt J.-P.   Rex A.   Sohr R.   Fink H.  

European Neuropsychopharmacology, Vol. 9, Iss. 4, 1999-06 ,pp. : 279-285

Elsevier

Access to resources Recommend Favorite